🇺🇸 FDA
Patent

US 8497287

Aminotetralin compounds as mu opioid receptor antagonists

granted A61KA61K47/12A61K47/14

Quick answer

US patent 8497287 (Aminotetralin compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K47/12, A61K47/14, A61K47/26, A61K9/0019